US 11969435
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted A61KA61K31/496A61K31/575
Quick answer
US patent 11969435 (Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors) held by Corcept Therapeutics Incorporated expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/496, A61K31/575, A61K31/7048, A61K45/06